MARIA GLORIA
SANCHEZ ANTOLIN
Investigadora no período 1997-2020
Complejo Asistencial Universitario de Burgos
Burgos, EspañaPublicacións en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (4)
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2017
-
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Clinical Gastroenterology and Hepatology, Vol. 15, Núm. 6, pp. 945-949.e1
2015
-
Barriers to HCV treatment in the era of triple therapy: A prospective multi-centred study in clinical practice
Liver International, Vol. 35, Núm. 2, pp. 401-408
-
High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain
Annals of Hepatology, Vol. 14, Núm. 4, pp. 477-486